nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydroergotamine—ABCB1—Dactinomycin—muscle cancer	0.18	0.258	CbGbCtD
Dihydroergotamine—ABCB1—Vincristine—muscle cancer	0.111	0.159	CbGbCtD
Dihydroergotamine—ABCB1—Etoposide—muscle cancer	0.102	0.146	CbGbCtD
Dihydroergotamine—ABCB1—Doxorubicin—muscle cancer	0.0692	0.0993	CbGbCtD
Dihydroergotamine—ABCB1—Methotrexate—muscle cancer	0.0671	0.0962	CbGbCtD
Dihydroergotamine—CYP3A4—Vincristine—muscle cancer	0.0664	0.0952	CbGbCtD
Dihydroergotamine—CYP3A4—Etoposide—muscle cancer	0.0608	0.0872	CbGbCtD
Dihydroergotamine—CYP3A4—Doxorubicin—muscle cancer	0.0415	0.0595	CbGbCtD
Dihydroergotamine—Rash papular—Doxorubicin—muscle cancer	0.00508	0.0168	CcSEcCtD
Dihydroergotamine—Gait disturbance—Vincristine—muscle cancer	0.00461	0.0152	CcSEcCtD
Dihydroergotamine—Tingling sensation—Etoposide—muscle cancer	0.00454	0.015	CcSEcCtD
Dihydroergotamine—Rigors—Etoposide—muscle cancer	0.00447	0.0148	CcSEcCtD
Dihydroergotamine—Dysphagia—Dactinomycin—muscle cancer	0.00316	0.0104	CcSEcCtD
Dihydroergotamine—Swelling—Etoposide—muscle cancer	0.003	0.00992	CcSEcCtD
Dihydroergotamine—Stupor—Methotrexate—muscle cancer	0.00293	0.00967	CcSEcCtD
Dihydroergotamine—Parosmia—Doxorubicin—muscle cancer	0.00292	0.00964	CcSEcCtD
Dihydroergotamine—Muscular weakness—Vincristine—muscle cancer	0.00288	0.00952	CcSEcCtD
Dihydroergotamine—Petechiae—Methotrexate—muscle cancer	0.00266	0.00877	CcSEcCtD
Dihydroergotamine—Speech disorder—Methotrexate—muscle cancer	0.00254	0.00839	CcSEcCtD
Dihydroergotamine—Pharyngitis—Dactinomycin—muscle cancer	0.00251	0.0083	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Vincristine—muscle cancer	0.00248	0.0082	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Vincristine—muscle cancer	0.00247	0.00816	CcSEcCtD
Dihydroergotamine—Musculoskeletal stiffness—Methotrexate—muscle cancer	0.00244	0.00805	CcSEcCtD
Dihydroergotamine—Cramp muscle—Etoposide—muscle cancer	0.00238	0.00788	CcSEcCtD
Dihydroergotamine—Herpes simplex—Methotrexate—muscle cancer	0.00237	0.00783	CcSEcCtD
Dihydroergotamine—Flushing—Dactinomycin—muscle cancer	0.00235	0.00776	CcSEcCtD
Dihydroergotamine—Rigors—Doxorubicin—muscle cancer	0.00232	0.00766	CcSEcCtD
Dihydroergotamine—Petechiae—Doxorubicin—muscle cancer	0.0023	0.0076	CcSEcCtD
Dihydroergotamine—Dysphagia—Etoposide—muscle cancer	0.00229	0.00756	CcSEcCtD
Dihydroergotamine—Chills—Dactinomycin—muscle cancer	0.00227	0.0075	CcSEcCtD
Dihydroergotamine—Bronchospasm—Etoposide—muscle cancer	0.00225	0.00744	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Vincristine—muscle cancer	0.00225	0.00743	CcSEcCtD
Dihydroergotamine—Sweating increased—Etoposide—muscle cancer	0.00223	0.00736	CcSEcCtD
Dihydroergotamine—Vaginal inflammation—Methotrexate—muscle cancer	0.00218	0.00722	CcSEcCtD
Dihydroergotamine—Cystitis noninfective—Methotrexate—muscle cancer	0.00213	0.00705	CcSEcCtD
Dihydroergotamine—Cystitis—Methotrexate—muscle cancer	0.00211	0.00697	CcSEcCtD
Dihydroergotamine—Depressed level of consciousness—Methotrexate—muscle cancer	0.00211	0.00697	CcSEcCtD
Dihydroergotamine—Vaginal infection—Methotrexate—muscle cancer	0.00206	0.00681	CcSEcCtD
Dihydroergotamine—Herpes simplex—Doxorubicin—muscle cancer	0.00205	0.00678	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Dactinomycin—muscle cancer	0.00204	0.00675	CcSEcCtD
Dihydroergotamine—Acute coronary syndrome—Etoposide—muscle cancer	0.00201	0.00664	CcSEcCtD
Dihydroergotamine—Myocardial infarction—Etoposide—muscle cancer	0.002	0.00661	CcSEcCtD
Dihydroergotamine—Malaise—Dactinomycin—muscle cancer	0.00199	0.00656	CcSEcCtD
Dihydroergotamine—Bladder pain—Methotrexate—muscle cancer	0.00198	0.00653	CcSEcCtD
Dihydroergotamine—Gait disturbance—Doxorubicin—muscle cancer	0.00194	0.0064	CcSEcCtD
Dihydroergotamine—Hiccups—Doxorubicin—muscle cancer	0.00189	0.00625	CcSEcCtD
Dihydroergotamine—Vaginal inflammation—Doxorubicin—muscle cancer	0.00189	0.00625	CcSEcCtD
Dihydroergotamine—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00189	0.00625	CcSEcCtD
Dihydroergotamine—Myalgia—Dactinomycin—muscle cancer	0.00188	0.0062	CcSEcCtD
Dihydroergotamine—Discomfort—Dactinomycin—muscle cancer	0.00185	0.00612	CcSEcCtD
Dihydroergotamine—Cystitis noninfective—Doxorubicin—muscle cancer	0.00185	0.0061	CcSEcCtD
Dihydroergotamine—Salivary hypersecretion—Doxorubicin—muscle cancer	0.00184	0.00607	CcSEcCtD
Dihydroergotamine—Influenza like illness—Doxorubicin—muscle cancer	0.00184	0.00607	CcSEcCtD
Dihydroergotamine—Cystitis—Doxorubicin—muscle cancer	0.00183	0.00603	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Etoposide—muscle cancer	0.00182	0.00602	CcSEcCtD
Dihydroergotamine—Agitation—Vincristine—muscle cancer	0.00181	0.00598	CcSEcCtD
Dihydroergotamine—Oedema—Dactinomycin—muscle cancer	0.0018	0.00594	CcSEcCtD
Dihydroergotamine—Vaginal infection—Doxorubicin—muscle cancer	0.00179	0.0059	CcSEcCtD
Dihydroergotamine—Vertigo—Vincristine—muscle cancer	0.00177	0.00584	CcSEcCtD
Dihydroergotamine—Anorexia—Dactinomycin—muscle cancer	0.00171	0.00566	CcSEcCtD
Dihydroergotamine—Bladder pain—Doxorubicin—muscle cancer	0.00171	0.00565	CcSEcCtD
Dihydroergotamine—Flushing—Etoposide—muscle cancer	0.0017	0.00562	CcSEcCtD
Dihydroergotamine—Hypertension—Vincristine—muscle cancer	0.0017	0.00561	CcSEcCtD
Dihydroergotamine—Myalgia—Vincristine—muscle cancer	0.00168	0.00554	CcSEcCtD
Dihydroergotamine—Abnormal vision—Doxorubicin—muscle cancer	0.00165	0.00545	CcSEcCtD
Dihydroergotamine—Chills—Etoposide—muscle cancer	0.00164	0.00543	CcSEcCtD
Dihydroergotamine—Mental disability—Doxorubicin—muscle cancer	0.00164	0.00542	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00164	0.00541	CcSEcCtD
Dihydroergotamine—Cerebrovascular accident—Methotrexate—muscle cancer	0.00162	0.00535	CcSEcCtD
Dihydroergotamine—Oedema—Vincristine—muscle cancer	0.00161	0.00531	CcSEcCtD
Dihydroergotamine—Decreased appetite—Dactinomycin—muscle cancer	0.00156	0.00516	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Vincristine—muscle cancer	0.00155	0.00513	CcSEcCtD
Dihydroergotamine—Fatigue—Dactinomycin—muscle cancer	0.00155	0.00512	CcSEcCtD
Dihydroergotamine—Pain—Dactinomycin—muscle cancer	0.00154	0.00508	CcSEcCtD
Dihydroergotamine—Muscle spasms—Etoposide—muscle cancer	0.00153	0.00506	CcSEcCtD
Dihydroergotamine—Anorexia—Vincristine—muscle cancer	0.00153	0.00506	CcSEcCtD
Dihydroergotamine—Eye pain—Doxorubicin—muscle cancer	0.00152	0.00503	CcSEcCtD
Dihydroergotamine—Hypotension—Vincristine—muscle cancer	0.0015	0.00496	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Dactinomycin—muscle cancer	0.00148	0.00489	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Etoposide—muscle cancer	0.00148	0.00489	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00147	0.00486	CcSEcCtD
Dihydroergotamine—Hot flush—Doxorubicin—muscle cancer	0.00147	0.00485	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00146	0.00484	CcSEcCtD
Dihydroergotamine—Menopausal symptoms—Doxorubicin—muscle cancer	0.00146	0.00481	CcSEcCtD
Dihydroergotamine—Insomnia—Vincristine—muscle cancer	0.00145	0.0048	CcSEcCtD
Dihydroergotamine—Paraesthesia—Vincristine—muscle cancer	0.00144	0.00477	CcSEcCtD
Dihydroergotamine—Malaise—Etoposide—muscle cancer	0.00144	0.00475	CcSEcCtD
Dihydroergotamine—Vertigo—Etoposide—muscle cancer	0.00143	0.00473	CcSEcCtD
Dihydroergotamine—Body temperature increased—Dactinomycin—muscle cancer	0.00142	0.0047	CcSEcCtD
Dihydroergotamine—Abdominal pain—Dactinomycin—muscle cancer	0.00142	0.0047	CcSEcCtD
Dihydroergotamine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.0014	0.00463	CcSEcCtD
Dihydroergotamine—Decreased appetite—Vincristine—muscle cancer	0.0014	0.00461	CcSEcCtD
Dihydroergotamine—Fatigue—Vincristine—muscle cancer	0.00138	0.00458	CcSEcCtD
Dihydroergotamine—Hypertension—Etoposide—muscle cancer	0.00138	0.00455	CcSEcCtD
Dihydroergotamine—Pain—Vincristine—muscle cancer	0.00137	0.00454	CcSEcCtD
Dihydroergotamine—Migraine—Doxorubicin—muscle cancer	0.00135	0.00447	CcSEcCtD
Dihydroergotamine—Discomfort—Etoposide—muscle cancer	0.00134	0.00443	CcSEcCtD
Dihydroergotamine—Face oedema—Doxorubicin—muscle cancer	0.00133	0.00438	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Dactinomycin—muscle cancer	0.00132	0.00438	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Vincristine—muscle cancer	0.00131	0.00434	CcSEcCtD
Dihydroergotamine—Confusional state—Etoposide—muscle cancer	0.00131	0.00433	CcSEcCtD
Dihydroergotamine—Asthenia—Dactinomycin—muscle cancer	0.00129	0.00426	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00127	0.00421	CcSEcCtD
Dihydroergotamine—Tachycardia—Etoposide—muscle cancer	0.00127	0.0042	CcSEcCtD
Dihydroergotamine—Abdominal pain—Vincristine—muscle cancer	0.00127	0.0042	CcSEcCtD
Dihydroergotamine—Body temperature increased—Vincristine—muscle cancer	0.00127	0.0042	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Etoposide—muscle cancer	0.00126	0.00416	CcSEcCtD
Dihydroergotamine—Anorexia—Etoposide—muscle cancer	0.00124	0.0041	CcSEcCtD
Dihydroergotamine—Diarrhoea—Dactinomycin—muscle cancer	0.00123	0.00406	CcSEcCtD
Dihydroergotamine—Hypotension—Etoposide—muscle cancer	0.00122	0.00402	CcSEcCtD
Dihydroergotamine—Muscular weakness—Doxorubicin—muscle cancer	0.00121	0.004	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Methotrexate—muscle cancer	0.00119	0.00392	CcSEcCtD
Dihydroergotamine—Dysphagia—Doxorubicin—muscle cancer	0.00119	0.00392	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Vincristine—muscle cancer	0.00118	0.00391	CcSEcCtD
Dihydroergotamine—Paraesthesia—Etoposide—muscle cancer	0.00117	0.00386	CcSEcCtD
Dihydroergotamine—Dyspnoea—Etoposide—muscle cancer	0.00116	0.00383	CcSEcCtD
Dihydroergotamine—Somnolence—Etoposide—muscle cancer	0.00116	0.00382	CcSEcCtD
Dihydroergotamine—Angina pectoris—Doxorubicin—muscle cancer	0.00116	0.00382	CcSEcCtD
Dihydroergotamine—Epistaxis—Methotrexate—muscle cancer	0.00115	0.00381	CcSEcCtD
Dihydroergotamine—Asthenia—Vincristine—muscle cancer	0.00115	0.00381	CcSEcCtD
Dihydroergotamine—Vomiting—Dactinomycin—muscle cancer	0.00114	0.00378	CcSEcCtD
Dihydroergotamine—Bronchitis—Doxorubicin—muscle cancer	0.00114	0.00377	CcSEcCtD
Dihydroergotamine—Rash—Dactinomycin—muscle cancer	0.00113	0.00375	CcSEcCtD
Dihydroergotamine—Decreased appetite—Etoposide—muscle cancer	0.00113	0.00374	CcSEcCtD
Dihydroergotamine—Fatigue—Etoposide—muscle cancer	0.00112	0.00371	CcSEcCtD
Dihydroergotamine—Pain—Etoposide—muscle cancer	0.00111	0.00368	CcSEcCtD
Dihydroergotamine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.0011	0.00364	CcSEcCtD
Dihydroergotamine—Diarrhoea—Vincristine—muscle cancer	0.0011	0.00363	CcSEcCtD
Dihydroergotamine—Pollakiuria—Doxorubicin—muscle cancer	0.0011	0.00362	CcSEcCtD
Dihydroergotamine—Pharyngitis—Methotrexate—muscle cancer	0.00109	0.0036	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Etoposide—muscle cancer	0.00107	0.00354	CcSEcCtD
Dihydroergotamine—Nausea—Dactinomycin—muscle cancer	0.00107	0.00353	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Etoposide—muscle cancer	0.00106	0.00352	CcSEcCtD
Dihydroergotamine—Dizziness—Vincristine—muscle cancer	0.00106	0.00351	CcSEcCtD
Dihydroergotamine—Visual impairment—Methotrexate—muscle cancer	0.00106	0.00349	CcSEcCtD
Dihydroergotamine—Urticaria—Etoposide—muscle cancer	0.00103	0.00342	CcSEcCtD
Dihydroergotamine—Body temperature increased—Etoposide—muscle cancer	0.00103	0.0034	CcSEcCtD
Dihydroergotamine—Abdominal pain—Etoposide—muscle cancer	0.00103	0.0034	CcSEcCtD
Dihydroergotamine—Conjunctivitis—Doxorubicin—muscle cancer	0.00103	0.0034	CcSEcCtD
Dihydroergotamine—Tinnitus—Methotrexate—muscle cancer	0.00102	0.00338	CcSEcCtD
Dihydroergotamine—Vomiting—Vincristine—muscle cancer	0.00102	0.00337	CcSEcCtD
Dihydroergotamine—Rash—Vincristine—muscle cancer	0.00101	0.00335	CcSEcCtD
Dihydroergotamine—Dermatitis—Vincristine—muscle cancer	0.00101	0.00334	CcSEcCtD
Dihydroergotamine—Headache—Vincristine—muscle cancer	0.00101	0.00332	CcSEcCtD
Dihydroergotamine—Epistaxis—Doxorubicin—muscle cancer	0.000998	0.0033	CcSEcCtD
Dihydroergotamine—Sinusitis—Doxorubicin—muscle cancer	0.000993	0.00328	CcSEcCtD
Dihydroergotamine—Chills—Methotrexate—muscle cancer	0.000984	0.00325	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Etoposide—muscle cancer	0.000959	0.00317	CcSEcCtD
Dihydroergotamine—Nausea—Vincristine—muscle cancer	0.000954	0.00315	CcSEcCtD
Dihydroergotamine—Rhinitis—Doxorubicin—muscle cancer	0.000952	0.00315	CcSEcCtD
Dihydroergotamine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000945	0.00312	CcSEcCtD
Dihydroergotamine—Pharyngitis—Doxorubicin—muscle cancer	0.000943	0.00312	CcSEcCtD
Dihydroergotamine—Asthenia—Etoposide—muscle cancer	0.000934	0.00308	CcSEcCtD
Dihydroergotamine—Pruritus—Etoposide—muscle cancer	0.000921	0.00304	CcSEcCtD
Dihydroergotamine—Visual impairment—Doxorubicin—muscle cancer	0.000915	0.00302	CcSEcCtD
Dihydroergotamine—Diarrhoea—Etoposide—muscle cancer	0.00089	0.00294	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Methotrexate—muscle cancer	0.000886	0.00293	CcSEcCtD
Dihydroergotamine—Tinnitus—Doxorubicin—muscle cancer	0.000886	0.00293	CcSEcCtD
Dihydroergotamine—Flushing—Doxorubicin—muscle cancer	0.000882	0.00291	CcSEcCtD
Dihydroergotamine—Malaise—Methotrexate—muscle cancer	0.000861	0.00285	CcSEcCtD
Dihydroergotamine—Dizziness—Etoposide—muscle cancer	0.00086	0.00284	CcSEcCtD
Dihydroergotamine—Vertigo—Methotrexate—muscle cancer	0.000858	0.00283	CcSEcCtD
Dihydroergotamine—Chills—Doxorubicin—muscle cancer	0.000852	0.00282	CcSEcCtD
Dihydroergotamine—Vomiting—Etoposide—muscle cancer	0.000827	0.00273	CcSEcCtD
Dihydroergotamine—Rash—Etoposide—muscle cancer	0.00082	0.00271	CcSEcCtD
Dihydroergotamine—Dermatitis—Etoposide—muscle cancer	0.00082	0.00271	CcSEcCtD
Dihydroergotamine—Headache—Etoposide—muscle cancer	0.000815	0.00269	CcSEcCtD
Dihydroergotamine—Arthralgia—Methotrexate—muscle cancer	0.000813	0.00269	CcSEcCtD
Dihydroergotamine—Myalgia—Methotrexate—muscle cancer	0.000813	0.00269	CcSEcCtD
Dihydroergotamine—Tension—Doxorubicin—muscle cancer	0.000811	0.00268	CcSEcCtD
Dihydroergotamine—Discomfort—Methotrexate—muscle cancer	0.000803	0.00265	CcSEcCtD
Dihydroergotamine—Nervousness—Doxorubicin—muscle cancer	0.000803	0.00265	CcSEcCtD
Dihydroergotamine—Muscle spasms—Doxorubicin—muscle cancer	0.000795	0.00263	CcSEcCtD
Dihydroergotamine—Confusional state—Methotrexate—muscle cancer	0.000786	0.0026	CcSEcCtD
Dihydroergotamine—Nausea—Etoposide—muscle cancer	0.000773	0.00255	CcSEcCtD
Dihydroergotamine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000767	0.00254	CcSEcCtD
Dihydroergotamine—Agitation—Doxorubicin—muscle cancer	0.00076	0.00251	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Methotrexate—muscle cancer	0.000753	0.00249	CcSEcCtD
Dihydroergotamine—Malaise—Doxorubicin—muscle cancer	0.000746	0.00246	CcSEcCtD
Dihydroergotamine—Vertigo—Doxorubicin—muscle cancer	0.000743	0.00245	CcSEcCtD
Dihydroergotamine—Anorexia—Methotrexate—muscle cancer	0.000743	0.00245	CcSEcCtD
Dihydroergotamine—Palpitations—Doxorubicin—muscle cancer	0.000731	0.00241	CcSEcCtD
Dihydroergotamine—Hypotension—Methotrexate—muscle cancer	0.000728	0.00241	CcSEcCtD
Dihydroergotamine—Hypertension—Doxorubicin—muscle cancer	0.000714	0.00236	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.00071	0.00235	CcSEcCtD
Dihydroergotamine—Insomnia—Methotrexate—muscle cancer	0.000705	0.00233	CcSEcCtD
Dihydroergotamine—Myalgia—Doxorubicin—muscle cancer	0.000704	0.00233	CcSEcCtD
Dihydroergotamine—Arthralgia—Doxorubicin—muscle cancer	0.000704	0.00233	CcSEcCtD
Dihydroergotamine—Anxiety—Doxorubicin—muscle cancer	0.000702	0.00232	CcSEcCtD
Dihydroergotamine—Paraesthesia—Methotrexate—muscle cancer	0.0007	0.00231	CcSEcCtD
Dihydroergotamine—Discomfort—Doxorubicin—muscle cancer	0.000696	0.0023	CcSEcCtD
Dihydroergotamine—Dyspnoea—Methotrexate—muscle cancer	0.000695	0.0023	CcSEcCtD
Dihydroergotamine—Somnolence—Methotrexate—muscle cancer	0.000693	0.00229	CcSEcCtD
Dihydroergotamine—Dry mouth—Doxorubicin—muscle cancer	0.000689	0.00227	CcSEcCtD
Dihydroergotamine—Dyspepsia—Methotrexate—muscle cancer	0.000686	0.00227	CcSEcCtD
Dihydroergotamine—Confusional state—Doxorubicin—muscle cancer	0.00068	0.00225	CcSEcCtD
Dihydroergotamine—Decreased appetite—Methotrexate—muscle cancer	0.000678	0.00224	CcSEcCtD
Dihydroergotamine—Oedema—Doxorubicin—muscle cancer	0.000675	0.00223	CcSEcCtD
Dihydroergotamine—Fatigue—Methotrexate—muscle cancer	0.000672	0.00222	CcSEcCtD
Dihydroergotamine—Pain—Methotrexate—muscle cancer	0.000666	0.0022	CcSEcCtD
Dihydroergotamine—Shock—Doxorubicin—muscle cancer	0.000664	0.00219	CcSEcCtD
Dihydroergotamine—Tachycardia—Doxorubicin—muscle cancer	0.000659	0.00218	CcSEcCtD
Dihydroergotamine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000652	0.00216	CcSEcCtD
Dihydroergotamine—Anorexia—Doxorubicin—muscle cancer	0.000643	0.00213	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Methotrexate—muscle cancer	0.000642	0.00212	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000637	0.00211	CcSEcCtD
Dihydroergotamine—Hypotension—Doxorubicin—muscle cancer	0.000631	0.00208	CcSEcCtD
Dihydroergotamine—Urticaria—Methotrexate—muscle cancer	0.000619	0.00205	CcSEcCtD
Dihydroergotamine—Body temperature increased—Methotrexate—muscle cancer	0.000616	0.00204	CcSEcCtD
Dihydroergotamine—Abdominal pain—Methotrexate—muscle cancer	0.000616	0.00204	CcSEcCtD
Dihydroergotamine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000615	0.00203	CcSEcCtD
Dihydroergotamine—Insomnia—Doxorubicin—muscle cancer	0.00061	0.00202	CcSEcCtD
Dihydroergotamine—Paraesthesia—Doxorubicin—muscle cancer	0.000606	0.002	CcSEcCtD
Dihydroergotamine—Dyspnoea—Doxorubicin—muscle cancer	0.000602	0.00199	CcSEcCtD
Dihydroergotamine—Somnolence—Doxorubicin—muscle cancer	0.0006	0.00198	CcSEcCtD
Dihydroergotamine—Dyspepsia—Doxorubicin—muscle cancer	0.000594	0.00196	CcSEcCtD
Dihydroergotamine—Decreased appetite—Doxorubicin—muscle cancer	0.000587	0.00194	CcSEcCtD
Dihydroergotamine—Fatigue—Doxorubicin—muscle cancer	0.000582	0.00192	CcSEcCtD
Dihydroergotamine—Pain—Doxorubicin—muscle cancer	0.000577	0.00191	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Methotrexate—muscle cancer	0.000574	0.0019	CcSEcCtD
Dihydroergotamine—Asthenia—Methotrexate—muscle cancer	0.000559	0.00185	CcSEcCtD
Dihydroergotamine—Feeling abnormal—Doxorubicin—muscle cancer	0.000556	0.00184	CcSEcCtD
Dihydroergotamine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000552	0.00182	CcSEcCtD
Dihydroergotamine—Pruritus—Methotrexate—muscle cancer	0.000551	0.00182	CcSEcCtD
Dihydroergotamine—Urticaria—Doxorubicin—muscle cancer	0.000536	0.00177	CcSEcCtD
Dihydroergotamine—Body temperature increased—Doxorubicin—muscle cancer	0.000534	0.00176	CcSEcCtD
Dihydroergotamine—Abdominal pain—Doxorubicin—muscle cancer	0.000534	0.00176	CcSEcCtD
Dihydroergotamine—Diarrhoea—Methotrexate—muscle cancer	0.000533	0.00176	CcSEcCtD
Dihydroergotamine—Dizziness—Methotrexate—muscle cancer	0.000515	0.0017	CcSEcCtD
Dihydroergotamine—Hypersensitivity—Doxorubicin—muscle cancer	0.000497	0.00164	CcSEcCtD
Dihydroergotamine—Vomiting—Methotrexate—muscle cancer	0.000496	0.00164	CcSEcCtD
Dihydroergotamine—Rash—Methotrexate—muscle cancer	0.000491	0.00162	CcSEcCtD
Dihydroergotamine—Dermatitis—Methotrexate—muscle cancer	0.000491	0.00162	CcSEcCtD
Dihydroergotamine—Headache—Methotrexate—muscle cancer	0.000488	0.00161	CcSEcCtD
Dihydroergotamine—Asthenia—Doxorubicin—muscle cancer	0.000484	0.0016	CcSEcCtD
Dihydroergotamine—Pruritus—Doxorubicin—muscle cancer	0.000477	0.00158	CcSEcCtD
Dihydroergotamine—Nausea—Methotrexate—muscle cancer	0.000463	0.00153	CcSEcCtD
Dihydroergotamine—Diarrhoea—Doxorubicin—muscle cancer	0.000462	0.00153	CcSEcCtD
Dihydroergotamine—Dizziness—Doxorubicin—muscle cancer	0.000446	0.00147	CcSEcCtD
Dihydroergotamine—Vomiting—Doxorubicin—muscle cancer	0.000429	0.00142	CcSEcCtD
Dihydroergotamine—Rash—Doxorubicin—muscle cancer	0.000426	0.00141	CcSEcCtD
Dihydroergotamine—Dermatitis—Doxorubicin—muscle cancer	0.000425	0.0014	CcSEcCtD
Dihydroergotamine—Headache—Doxorubicin—muscle cancer	0.000423	0.0014	CcSEcCtD
Dihydroergotamine—Nausea—Doxorubicin—muscle cancer	0.000401	0.00132	CcSEcCtD
